FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129315073> ?p ?o ?g. }

• W2129315073 endingPage "1616" @default.
• W2129315073 startingPage "1608" @default.
• W2129315073 abstract "The drug of choice for treatment of Streptococcus pneumoniae infection is generally a penicillin (including amoxicillin). Targeted therapy is, however, rarely used, because results of definitive diagnostic tests for pneumonia are not available for several days. Thus, broad-spectrum antibiotics are used for empirical treatment of pneumonia to cover both typical and atypical pathogens. Our purpose was to assess the usefulness of a strategy of targeted antimicrobial therapy based on the results of a rapid urinary antigen test for S. pneumoniae. Military trainees with pneumonia were prospectively assigned to 2 groups: patients with positive urinary antigen test results who were treated with amoxicillin (1000 mg 3 times per day), and patients with negative urinary antigen test results who were treated with clarithromycin (500 mg 2 times per day). The duration of therapy was 5–10 days for both groups. A total of 219 evaluable patients were enrolled in the study. The most common causes of pneumonia were S. pneumoniae, Chlamydia pneumoniae, and Mycoplasma pneumoniae. Patients with positive urinary antigen test results had illness of greater severity at the time of study entry. Twenty-two percent of patients had positive urinary antigen test results (i.e., the amoxicillin group), and 78% had negative urinary antigen test results (i.e., the clarithromycin group). The clinical success rates were 94% for the clarithromycin group and 90% for the amoxicillin group (P = not significant). None of the patients who were classified as having treatment failure died. Resolution of clinical manifestations was slower for patients with pneumococcal pneumonia defined by a positive urinary antigen test result. The urine antigen test allowed targeted use of a penicillin (amoxicillin) for young immunocompetent individuals with nonsevere, community-acquired pneumonia. Clarithromycin was highly effective against both S. pneumoniae pneumonia and pneumonia due to atypical pathogens." @default.
• W2129315073 created "2016-06-24" @default.
• W2129315073 creator A5013533794 @default.
• W2129315073 creator A5021725052 @default.
• W2129315073 creator A5024325837 @default.
• W2129315073 creator A5029139734 @default.
• W2129315073 creator A5041729076 @default.
• W2129315073 creator A5070581855 @default.
• W2129315073 date "2005-06-01" @default.
• W2129315073 modified "2023-10-18" @default.
• W2129315073 title "Management of Nonsevere Pneumonia in Military Trainees with the Urinary Antigen Test for Streptococcus pneumoniae: An Innovative Approach to Targeted Therapy" @default.
• W2129315073 cites W1969516847 @default.
• W2129315073 cites W1984883296 @default.
• W2129315073 cites W1999765220 @default.
• W2129315073 cites W2003312939 @default.
• W2129315073 cites W2009773803 @default.
• W2129315073 cites W2022224398 @default.
• W2129315073 cites W2040919444 @default.
• W2129315073 cites W2042679455 @default.
• W2129315073 cites W2045291026 @default.
• W2129315073 cites W2054703106 @default.
• W2129315073 cites W2064243105 @default.
• W2129315073 cites W2080351368 @default.
• W2129315073 cites W2086971053 @default.
• W2129315073 cites W2097295506 @default.
• W2129315073 cites W2102361557 @default.
• W2129315073 cites W2107739727 @default.
• W2129315073 cites W2109366931 @default.
• W2129315073 cites W2111739098 @default.
• W2129315073 cites W2114366737 @default.
• W2129315073 cites W2123324969 @default.
• W2129315073 cites W2142230428 @default.
• W2129315073 cites W2152529946 @default.
• W2129315073 cites W2159045466 @default.
• W2129315073 cites W2160098107 @default.
• W2129315073 cites W2160907943 @default.
• W2129315073 cites W2163233433 @default.
• W2129315073 cites W2164351477 @default.
• W2129315073 cites W2165005886 @default.
• W2129315073 cites W2169455258 @default.
• W2129315073 cites W2320270386 @default.
• W2129315073 cites W2440264042 @default.
• W2129315073 cites W4230034839 @default.
• W2129315073 cites W4237196463 @default.
• W2129315073 cites W4300658240 @default.
• W2129315073 doi "https://doi.org/10.1086/429919" @default.
• W2129315073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15889358" @default.
• W2129315073 hasPublicationYear "2005" @default.
• W2129315073 type Work @default.
• W2129315073 sameAs 2129315073 @default.
• W2129315073 citedByCount "60" @default.
• W2129315073 countsByYear W21293150732012 @default.
• W2129315073 countsByYear W21293150732013 @default.
• W2129315073 countsByYear W21293150732014 @default.
• W2129315073 countsByYear W21293150732015 @default.
• W2129315073 countsByYear W21293150732016 @default.
• W2129315073 countsByYear W21293150732017 @default.
• W2129315073 countsByYear W21293150732018 @default.
• W2129315073 countsByYear W21293150732020 @default.
• W2129315073 countsByYear W21293150732021 @default.
• W2129315073 countsByYear W21293150732022 @default.
• W2129315073 crossrefType "journal-article" @default.
• W2129315073 hasAuthorship W2129315073A5013533794 @default.
• W2129315073 hasAuthorship W2129315073A5021725052 @default.
• W2129315073 hasAuthorship W2129315073A5024325837 @default.
• W2129315073 hasAuthorship W2129315073A5029139734 @default.
• W2129315073 hasAuthorship W2129315073A5041729076 @default.
• W2129315073 hasAuthorship W2129315073A5070581855 @default.
• W2129315073 hasBestOaLocation W21293150732 @default.
• W2129315073 hasConcept C126322002 @default.
• W2129315073 hasConcept C203014093 @default.
• W2129315073 hasConcept C2776409635 @default.
• W2129315073 hasConcept C2776962512 @default.
• W2129315073 hasConcept C2777914695 @default.
• W2129315073 hasConcept C2779215961 @default.
• W2129315073 hasConcept C2779708577 @default.
• W2129315073 hasConcept C2780122209 @default.
• W2129315073 hasConcept C2781253189 @default.
• W2129315073 hasConcept C501593827 @default.
• W2129315073 hasConcept C71924100 @default.
• W2129315073 hasConcept C77411442 @default.
• W2129315073 hasConcept C86803240 @default.
• W2129315073 hasConcept C89423630 @default.
• W2129315073 hasConceptScore W2129315073C126322002 @default.
• W2129315073 hasConceptScore W2129315073C203014093 @default.
• W2129315073 hasConceptScore W2129315073C2776409635 @default.
• W2129315073 hasConceptScore W2129315073C2776962512 @default.
• W2129315073 hasConceptScore W2129315073C2777914695 @default.
• W2129315073 hasConceptScore W2129315073C2779215961 @default.
• W2129315073 hasConceptScore W2129315073C2779708577 @default.
• W2129315073 hasConceptScore W2129315073C2780122209 @default.
• W2129315073 hasConceptScore W2129315073C2781253189 @default.
• W2129315073 hasConceptScore W2129315073C501593827 @default.
• W2129315073 hasConceptScore W2129315073C71924100 @default.
• W2129315073 hasConceptScore W2129315073C77411442 @default.
• W2129315073 hasConceptScore W2129315073C86803240 @default.
• W2129315073 hasConceptScore W2129315073C89423630 @default.
• W2129315073 hasIssue "11" @default.

• next